Another positive EBITDA of $0.5M, an impressive $7.5M turnaround.
We’re firmly on the path to profitability, and there’s no way we’ll stay under 20c for long.
Momentum is building, and we’re accelerating toward sustained profitability.
Key Highlights
- Robust 1HY25 Group Performance: Executing successfully against Bubs’ strategic plan
- Statutory NPAT of $3.6M, an $11.2M improvement YoY.
- EBITDA of $0.5M, a $7.5M uplift from 1HY24
- Cash flow transformation: Operating cash outflow reduced to just $0.5M (vs. $12.2M in 1HY24), with a strong liquidity position—$17.2M in cash plus $5.0M in undrawn debt
- Gross profit margins hitting 50%, well ahead of plan.
- Revenue up 23% on pcp to $48M, all regions showing strong growth over pcp.
- Forums
- ASX - By Stock
- BUB
- Ann: Bubs Australia - Half Year Results Presentation
BUB
bubs australia limited
Add to My Watchlist
9.09%
!
18.0¢

Ann: Bubs Australia - Half Year Results Presentation, page-6
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
18.0¢ |
Change
0.015(9.09%) |
Mkt cap ! $160.7M |
Open | High | Low | Value | Volume |
16.0¢ | 18.0¢ | 16.0¢ | $1.202M | 7.066M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 13235 | 17.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
18.0¢ | 804760 | 20 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 13235 | 0.170 |
8 | 259888 | 0.165 |
10 | 265748 | 0.160 |
29 | 1576022 | 0.155 |
22 | 1411921 | 0.150 |
Price($) | Vol. | No. |
---|---|---|
0.180 | 804760 | 20 |
0.185 | 912905 | 10 |
0.190 | 292664 | 8 |
0.195 | 228281 | 4 |
0.200 | 710650 | 16 |
Last trade - 16.20pm 26/06/2025 (20 minute delay) ? |
Featured News
BUB (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online